Your browser doesn't support javascript.
loading
Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al.
D'Silva, Kristin M; Serling-Boyd, Naomi; Wallwork, Rachel; Hsu, Tiffany Y-T; Sparks, Jeffrey A; Wallace, Zachary Scott.
Afiliación
  • D'Silva KM; Division of Rheumatology, Allergy, and Immunology, Harvard Medical School, Boston, Massachusetts, USA.
  • Serling-Boyd N; Division of Rheumatology, Allergy, and Immunology, Harvard Medical School, Boston, Massachusetts, USA.
  • Wallwork R; Division of Rheumatology, Allergy, and Immunology, Harvard Medical School, Boston, Massachusetts, USA.
  • Hsu TY; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Sparks JA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Wallace ZS; Division of Rheumatology, Allergy, and Immunology, Harvard Medical School, Boston, Massachusetts, USA zswallace@partners.org.
Ann Rheum Dis ; 81(8): e135, 2022 08.
Article en En | MEDLINE | ID: mdl-32660976

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Antirreumáticos / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Antirreumáticos / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos